KERRY GEIGER: Open Payments
NPI 1932643004 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 16 payments from 8 companies in 2025. Trend: 2023 $86 · 2024 $545 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $157 |
| ABBVIE INC. | 1 | $90 |
| Janssen Pharmaceuticals, Inc | 2 | $65 |
| Almatica Pharma LLC | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Alkermes, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $24 |
| Braeburn Inc. | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, INVEGA SUSTENNA, LOREEV XR, AUSTEDO XR, ARISTADA, SUBLOCADE, BRIXADI.
Industry payments across FL — which companies pay providers there.
